Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib

Leukemia and Lymphoma

Volumn 52, Issue 2, 2011, Pages 335-338

  Burbury, Kate ^a   Chew, Lee Ping ^a   Westerman, David ^a,b   Catalano, Alberto ^c   Seymour, John F ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; CD2 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; FIP1 LIKE 1 PROTEIN; HYDROXYUREA; IMATINIB; MEMBRANE PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PREDNISOLONE; TRYPTASE; UNCLASSIFIED DRUG;

AGED; AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CD4 CD8 RATIO; CHRONIC EOSINOPHILIC LEUKEMIA; CLONAL VARIATION; CLONE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; EOSINOPHILIA; EOSINOPHILIC LEUKEMIA; FUSION GENE; GENE EXPRESSION; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; LETHARGY; LETTER; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; CELL LINEAGE; CHRONIC DISEASE; CLONE CELLS; HUMANS; HYPEREOSINOPHILIC SYNDROME; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, T-CELL; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TREATMENT OUTCOME;

EID: 79551625447     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.534210     Document Type: Letter

References (15)

1. Bain B. The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica 2004;89:133-137.
2. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-1214.
3. Ravoet M, Sibille C, Gu C, et al. Molecular profiling of D3-CD4'T cells from patients with the lymcytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood 2009;114:2969-2983.
4. Galimberti S, Ciabatti E, Ottimo F, et al. Cell clonality in hypereosinophilic syndrome: what pathogenetic role? Clin Exp Rheumatol 2007;25:17-22.
5. Helbig G, Wieczorkiewicz A, Dziaczkowska-Suszek J, Majewski M, Kyrcz-Krzemien S. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Haematologica 2009;94:1236-1241.
6. Robyn J, Lemery S, McCoy JP, et al. Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRApositive hypereosinophilic syndrome. Br J Haematol 2006; 132:286-292.
7. Pardanani A, Reeder T, Porrata LF, et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 2003;101:3391-3397.
8. Roche-Lestienne C, Lepers S, Soenen-Cornu V, et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia 2005;19:792-798.
9. Vaklavas C, Tefferi A, Butterfield J, et al. 'Idiopathic' eosinophilia with an occult T-cell clone: prevalence and clinical course. Leuk Res 2007;31:691-694.
10. Klion AD, Robyn J, Akin C, et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004 ;103:473-478.
11. Metzgeroth G, Walz C, Score J, et al. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia 2007;21:1183-1188.
12. von Bubnoff N, Sandherr M, Schlimok G, et al. Myeloid blast crisis evolving during imatinib treatment of an FIP1L1- PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia. Leukemia 2005;19:286-287.
13. Bain BJ. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Haematologica 2010;95:696-698.
14. Simon HU, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-1120.
15. Yamada Y, Rothenberg ME, Lee AW, et al. The FIP1L1- PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood 2006;107:4071-4079.